Include All CSL Behring Country Sites
With cutting-edge facilities, technologies and technical expertise, Seqirus will be a reliable supplier of seasonal influenza vaccine with the ability to rapidly respond to pandemic threats.
Read More >
Welcome to Seqirus
In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second ...
FDA approval for FLUCELVAX QUADRIVALENT™ (Influenza Vaccine) for people four years of age and older
The first four-strain, cell culture-derived, ...
Seqirus Honored with National Award for Outstanding Efforts in Influenza Prevention
#KnockOutFlu Campaign Drove Home the Importance ...
Seqirus Commemorates 100 Years of Parent Company, CSL Limited
Delivering on its promise to develop innovative ...
© 2016 Seqirus